HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Advanced stomach and pancreas cancer successfully treated with combination chemotherapy with S-1/paclitaxel/lentinan.

Abstract
We report a case of stomach and pancreas cancers that showed marked responses to combination chemotherapy consisting of S-1, paclitaxel (PTX), and lentinan (LNT). A 67-year-old Japanese man was referred to our hospital in July 2005, diagnosed with advanced gastric cancer. Subsequent examination revealed the existence of cancers in the stomach and pancreas, with lymph nodes and peritoneal metastasis and ascites. The patient received combined chemotherapy (one course comprised 3 weeks) with S-1 (100 mg/body, day 1-14 followed by withdrawal for 1 week), PTX (50 mg/m2, day 1 and day 8), and LNT (2 mg/m2, day 1, day 8 and day 15). After completion of 4 courses, the patient achieved partial response (PR), with complete disappearance of the primary gastric tumor and ascites. He maintained in PR for 17 months. We analyzed Th1/ Th2 ratio and LNT binding rate to monocytes by flow cytometry. Combination chemotherapy with S-1/PTX/LNT can be an effective treatment for unresectable advanced gastric carcinoma.
AuthorsEiji Kubota, Hiromi Kataoka, Kazuki Hayashi, Takeshi Kamiya, Makoto Sasaki, Naotaka Ogasawara, Tomonori Yamada, Tsuneya Wada, Yoshinori Mori, Tsutomu Mizoshita, Takaya Shimura, Takashi Mizushima, Yasuyuki Okamoto, Hirotaka Ohara, Takashi Joh
JournalHepato-gastroenterology (Hepatogastroenterology) 2009 Jan-Feb Vol. 56 Issue 89 Pg. 106-10 ISSN: 0172-6390 [Print] Greece
PMID19453038 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Paclitaxel
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Humans
  • Lymphatic Metastasis
  • Male
  • Paclitaxel (administration & dosage)
  • Pancreatic Neoplasms (diagnostic imaging, drug therapy, pathology)
  • Peritoneal Neoplasms (diagnostic imaging, drug therapy, secondary)
  • Stomach Neoplasms (diagnostic imaging, drug therapy, pathology)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: